Hepatitis B trials in Hong Kong
11 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleA Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B
- Where
- Hong Kong
- Age
- 18 years to 70 years
- People
- 88 worldwide
- Run by
- IntegerBio
See details and how to joinNCT07389044 - Phase 1Taking peopleA Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection
- Where
- Hong Kong, Shatin
- Age
- 18 years and over
- People
- 48 worldwide
- Run by
- GigaGen, Inc.
See details and how to joinNCT07024641 - Phase 1Taking peoplePhase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B
- Where
- Hong Kong
- Age
- 18 years to 70 years
- People
- 45 worldwide
- Run by
- Precision BioSciences, Inc.
See details and how to joinNCT06680232 · EU 2025-524157-13-00 - Phase 1/2Taking peopleA Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis B
- Where
- Hong Kong
- Age
- 18 years to 64 years
- People
- 66 worldwide
- Run by
- nChroma Bio
See details and how to joinNCT07200193 · EU 2025-523619-12-00 - Phase 1Not yet taking people in Hong KongStudy of AHB-171 in Chronic Hepatitis B Participants
- Where
- Hong Kong
- Age
- 18 years to 65 years
- People
- 144 worldwide
- Run by
- AusperBio Therapeutics Inc.
See details and how to joinNCT07617194 - No phaseEnrolling by invitationA Long-term Observational Study in Participants Who Have Received PBGENE-HBV
- Where
- Hong Kong
- Age
- 19 years to 80 years
- People
- 45 worldwide
- Run by
- Precision BioSciences, Inc.
See details and how to joinNCT07254208 - Phase 4Taking peopleSGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus
- Where
- Hong Kong
- Age
- 18 years and over
- People
- 412
- Run by
- Chinese University of Hong Kong
See details and how to joinNCT06364930 - Phase 1Taking peoplePhase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B
- Where
- Hong Kong
- Age
- 18 years to 75 years
- People
- 36 worldwide
- Run by
- Tune Therapeutics, Inc.
See details and how to joinNCT06671093 - Phase 4Taking peopleCessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK)
- Where
- Hong Kong
- People
- 2,000
- Run by
- Humanity & Health Medical Group Limited
See details and how to joinNCT03792919 - Phase 1/2Taking peopleA Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma
- Where
- Hong Kong
- Age
- 18 years to 70 years
- People
- 46 worldwide
- Run by
- SCG Cell Therapy Pte. Ltd.
See details and how to joinNCT05417932 - No phaseTaking peopleLong-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)
- Where
- Hong Kong, Shatin
- Age
- 20 years to 70 years
- People
- 50 worldwide
- Run by
- Arbutus Biopharma Corporation
See details and how to joinNCT06277037